)
)
Edge16 Oct 2026
Winner, Winner: The Chicken McNugget Story
How a 1940s breeding contest, a Cornell food scientist, and a hedge by Ray Dalio helped McDonald's turn the Chicken McNugget into a fast-food icon.
Clariane
Clariane (CLARI) investor relations material
Clariane Q3 2026 TU earnings summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Q3 2026 TU earnings summary29 Oct, 2026
Executive summary
9M 2026 revenue reached €4,051m, up 4.7% organically and 1.9% reported; Q3 organic growth accelerated to 4.9%, with all activities and geographies contributing.
Growth reflected higher volumes, positive pricing and case mix, and rising nursing-home occupancy.
Nearly €2.3bn of refinancing extended maturities to 2030–2032; all 2023–2026 and 2025–2028 objectives were confirmed.
Financial highlights
9M revenue rose from €3,976m to €4,051m: +1.9% reported and +4.7% organically.
9M revenue bridge: +€62m from volume (+1.6%), +€118m from pricing and case mix (+3.1%), -€121m from perimeter effects (-3.0%) and +€17m from other effects (+0.2%).
Q3 revenue was €1,352m, up 2.4% reported and 4.9% organically; -€31m perimeter impact was offset by +€21m volume and +€42m pricing and case mix.
Outlook and guidance
2023–2026 targets: ~5% average annual pro forma organic revenue growth; 100–150 bps pre-IFRS 16 EBITDA margin improvement by end-2026 versus 10.5% in 2023, excluding real estate development.
By end-2026, pre-IFRS 16 net financial debt target is ~€3bn on a comparable balance-sheet basis, with Wholeco leverage below 5.5x.
2025–2028 targets: ~4% annual pro forma revenue growth, 7%–9% pre-IFRS 16 EBITDA growth, 11%–14% EBITDA OpCo growth, and Wholeco leverage ~5x by end-2028.
Annual investment envelope remains ~€300m, split roughly equally between operating and development CapEx.
Partial view of Summaries dataset, powered by Quartr API
AI can get things wrong. Verify important information.Research faster. Power your platform.
Latest events from Clariane
- Strong organic growth, margin expansion, and successful refinancing support 2026 targets.CLARI
Q2 2026 - Q1 2026 organic revenue rose 4.9% to €1,336m, with improved occupancy and liquidity.CLARIQ1 2026 TU
- 2025 saw 4.5% organic growth, €390m debt reduction, and improved margins and liquidity.CLARIQ4 2025
- Organic revenue up 4.9% YTD, margin and leverage targets on track after asset disposals and bond issue.CLARIQ3 2025 TU
- Strong revenue growth, improved leverage, and refinancing progress despite net loss.CLARIH1 2024
- Organic revenue up 6.3%, asset disposals and liquidity measures support 2024 guidance.CLARIQ3 2024 TU
- All resolutions passed as financials improved, governance renewed, and ESG progress advanced.CLARIAGM 2025
- Q1 2025 organic revenue up 4.8%, occupancy and disposals progress support 2025 targets.CLARIQ1 2025
- Strong revenue and EBITDA growth, improved margins, and accelerated deleveraging for 2025.CLARIQ4 2024
Next Clariane earnings date
Q4 202625 Feb, 2027
Clariane
Next Clariane earnings date
Q4 202625 Feb, 2027
AI chat
Ask anything. Verify everything.
Ask across every event and document from public companies. Each answer links back to the exact line in the transcript, slide or filing it came from.Learn moreFind what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.)
Trust every finding
50m+ first-party documents. Every output traceable to its source.Find what matters
AI across all first-party IR material. Live calls, transcripts, slides, filings.Trust every finding
50m+ first-party documents. Every output traceable to its source.Automations
Zero in on what matters
Define the prompt once. It runs the moment a company publishes or on a schedule you set. Outputs map to the exact signals you choose.Learn more)
Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.)
Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Event-triggered research
Runs when a company publishes new material. Trigger on the first published document for the earliest possible run, or wait for a specific one.Scheduled research
Runs on a recurring cadence you set. Daily, weekly, monthly, or quarterly, for aggregate reads across a period rather than a single event.Live audio & transcripts
Be first
Join any earnings call live in one click, with no manual registration. Follow the transcript as it happens and jump straight to the moments that matter.Learn more)
Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.)
Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Live earnings calls
Join any call in one click. The audio keeps playing while you work elsewhere in Quartr.Live transcripts
Speaker-by-speaker, in real time. Searchable across every live and historical call.Quartr MCP connects your AI environment to 17K+ public companies
Pull live transcripts, filings, and slides into Claude or Codex via MCP. Combine Quartr's global IR data with any other dataset. Run agentic research and monitoring.
Included with Quartr Pro at no extra cost.Learn more
Quartr's AI stands out because it only pulls clean, first-party data from public companies. In investing, that's everything.
Jamie Ross
Investment Manager, GAM Investments
GAM
GAM
Research that used to take hours now takes seconds with Quartr Pro. Tracking shifts in tone or extracting tables, it's as simple as typing a query.
Tom O'Hara
Investment Director
Ciena
Ciena
Before Quartr we spent hours manually compiling insights through the peer earnings cycle. Now, these tasks are done faster, with greater precision.
Gregg Lampf
VP of Investor Relations
Protean
Protean
Being able to ask specific questions across years of transcripts and reports and instantly get verified answers is a game-changer.
Pontus Dackmo
CEO & Investment Manager
)
)
Frequently asked questions
Clariane SE, formerly known as Korian, is a French company specializing in elder and disabled care services. It operates a network of facilities across several European countries, including nursing homes, post-acute and rehabilitation clinics, assisted living facilities, and home care services. The company's operations are divided into three primary segments: Long-Term Care, Specialty Care, and Community Care. Clariane serves a diverse population, focusing on providing medical support and daily living assistance to elderly and vulnerable individuals. Headquartered in Paris, France, Clariane SE is publicly traded on Euronext Paris.